Executive PageTop Articles

President’s Page: The second Congress of the European Academy of Neurology in Copenhagen

June 6, 2016

Deuschl 2015 Fotoby Günther Deuschl

The 2nd congress of the EAN took place May 28-31, 2016 at the Bella Conference Center in Copenhagen. We had 5500 attendees who took part in 40 Symposia, focused workshops and special sessions. Among the many highlights were the outstanding presentations by the awardees of the Romberg, Golgi and Brown-Séquard lectures during the presidents plenary and the last-minute session on the ‘epidemiology, clinical presentations and immunology of Zika-Virus induced neurological diseases’ (This session can be viewed on the members-only part of the EAN-website). More than 4500 participants attended the 40 educational events with many new innovations like case-based facilitated workshops, more hands-on courses and career-development sessions. More than 1500 abstracts were presented in 28 oral and 117 electronic poster sessions.
Being the second congress of our Society the scientific programme was completely designed by our Programme committee under the leadership of Paul Boon and by our education committee chaired by Hannah Cock. The local organizing committee chaired by Mads Ravenborg has significantly worked on giving the congress a local flavor and has shown the brightness of Danish and Scandinavian Neurology to the participants. The EAN headoffice and the PCO Congrex have splendidly organised the congress in this outstanding venue. All of them deserve the gratitude of the Society.
Continuous innovations every year with cutting edge science and high-level education are the benchmark for us and the Society is focused to achieve this. The congress was a true meeting point for neurologists from Europe and all over the world. Particularly many sessions were organised with European Specialty Societies caring for special diseases. Collaborations with further Societies have been signed in Copenhagen and EAN feels part of a neurology coalition working for the best of patients with neurologic diseases. Like every year this spirit was part of the congress atmosphere and social interactions were a top priority. Some of this spirit has been picked in the photos below.

 

You may also like

Interview with Prof. Olof Flodmark, President of EBNI

January 1, 2019

Lisbon 2018: European Board Exam – Neurology

March 1, 2018

President’s Page: The second term of office of the EAN board

July 1, 2016

Lisbon 2018: Which session you should not miss…

January 9, 2018

Research Training Fellowship 2018 Report

July 16, 2019

Amsterdam 2017: Report on Symposium 6: Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)

August 1, 2017

Impact of COVID-19 pandemic in a peripheral hospital of northern Portugal – personal experience from a Neurology resident

April 16, 2020

Country of the month: Albania

August 1, 2016

Oslo 2019: Report on Symposium 2 ‘Insights into Headache Pathophysiology’

June 30, 2019
Dear EAN members, dear friends, It is my pleasure to give you an update on behalf of the EAN Scientific Committee following a busy year since my appointment as chair. It has been a privilege to be so deeply involved in the scientific activities of the EAN and to work closely with an amazing community of people who are so dedicated to the advancement of neurology. One of the strongest threads within that community is the EAN’s group of Scientific Panels, which are often referred to as the organisation’s ‘scientific backbone’. The panels have a hand in everything the EAN does from a scientific point of view, including coordinating clinical research, disseminating good practice, assisting in planning the EAN annual congress, supporting the EAN’s educational efforts, and producing guidelines that assist neurologists in daily practice. All of this work requires a considerable amount of oversight, and this is why each panel is run by its own Management Group, elected by the panel members. Being a part of one of these Management Groups (PDF) is an opportunity to play a direct part in determining the direction of scientific progress within Europe, and I am excited to say that the call for applications to stand for election will be announced in September. All panel members and EAN individual members are eligible to apply to be candidates, with the vote being held among the existing panel members in autumn. I would like to urge every neurologist with a passion for the scientific future of their special area of interest to consider standing for election to the relevant Management Group and to look out for the call for applications later this month. I can tell you from personal experience that fulfilling a role such as this within the structure of the EAN is a fascinating and extremely rewarding experience. The chance to take on such a unique leadership position should not be missed! The most satisfying aspect of being involved in the EAN’s organisational structure is surely seeing all the hard work and planning come to fruition when a small idea evolves into a newly launched project. One such example is the 1st EAN Science School, taking place in Salzburg next March. The idea of the Science School is to offer early career neurologists with an interest in translational research a new avenue for learning about basic pathomechanisms of neurological disorders. Application for this very first edition, on ‘Pathophysiology of disorders of the nervous system’, closed last week and we have been delighted with the level of interest. It was a pleasure to be part of the task force in charge of planning this new project and I look forward to seeing it officially transferred to the hands of the Scientific Committee after a successful event and evaluation in spring. Of our ongoing activities, one of the most significant is the EAN Neuro-covid Registry, which aims to collate epidemiological data on neurological manifestations in patients with COVID-19 infection reported by neurologists in outpatient services, emergency rooms, and hospital departments. We currently have 1,542 patients entered in the database, from 35 centres across 23 countries. So far, 29 patients have been followed for 12 months and 387 have completed the 6-months follow up. This is a decent start, but I would like to strongly encourage EAN members and their institutions to get involved and contribute cases to what will become an invaluable resource for neurologists and clinicians to improve care for Covid-19 patients. Finally, I would like share a word on a forthcoming collaboration between EAN and the Human Brain Project in December, that I think will interest a lot of EAN members. The EAN-EBRAINS joint workshop on ‘The future of medical data sharing in clinical neurosciences’ will be a three-day virtual event that aims to discuss issues and challenges associated with data sharing in Europe, from ethics to data safety and privacy, including those specific to data federation, such as the development and validation of federated algorithms. The whole workshop is completely free of charge and registration is open until 25 November, so please check out the details and sign up! I wish you all a healthy and pleasant autumn and I look forward to updating you again. Best wishes Thomas Berger Chair of the EAN Scientific Committee

Executive Page: Get involved! Management Group elections, Neuro-covid registry and more

September 1, 2021

Leave a Comment